POINT: Yes, Biotech Is In A Bubble
This article was originally published in Scrip
Executive Summary
It may be too early to determine whether biopharma is nearing the end of a summer slowdown or preparing to see an investment and dealmaking bubble burst, but there are a few pins poised to pop the proverbial bubble, leaving "When?" as the biggest unanswered question.